Blog

Lenalidomide Boosts Overall Survival After Stem Cell Tx – MedPage Today

Lenalidomide Boosts Overall Survival After Stem Cell Tx
MedPage Today
Lenalidomide (Revlimid) maintenance boosted overall survival (OS) and progression-free survival (PFS) compared with placebo or observation following autologous stemcell transplantation (ASCT) in patients with newly diagnosed multiple myeloma …

2017-10-10 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.